REPORT ID 3345

United States Megestrol Market Report 2017

Publish Date
13-Dec-17
Pages
105
Format
Electronic (PDF)

In this report, the United States Megestrol market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Megestrol in these regions, from 2012 to 2022 (forecast).

United States Megestrol market competition by top manufacturers/players, with Megestrol sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Sandoz
    GSK
    Mayne Pharma Inc
    Novartis
    Mylan
    Bristol Myers Squibb
    Abnova
    Abbott
    Takeda
    Guccess

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Injection
    Freeze-Dried Powder
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Megestrol Market Report 2017
1 Megestrol Overview
    1.1 Product Overview and Scope of Megestrol
    1.2 Classification of Megestrol by Product Category
        1.2.1 United States Megestrol Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Megestrol Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Injection
        1.2.4 Freeze-Dried Powder
    1.3 United States Megestrol Market by Application/End Users
        1.3.1 United States Megestrol Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 United States Megestrol Market by Region
        1.4.1 United States Megestrol Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Megestrol Status and Prospect (2012-2022)
        1.4.3 Southwest Megestrol Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Megestrol Status and Prospect (2012-2022)
        1.4.5 New England Megestrol Status and Prospect (2012-2022)
        1.4.6 The South Megestrol Status and Prospect (2012-2022)
        1.4.7 The Midwest Megestrol Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Megestrol (2012-2022)
        1.5.1 United States Megestrol Sales and Growth Rate (2012-2022)
        1.5.2 United States Megestrol Revenue and Growth Rate (2012-2022)

2 United States Megestrol Market Competition by Players/Suppliers
    2.1 United States Megestrol Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Megestrol Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Megestrol Average Price by Players/Suppliers (2012-2017)
    2.4 United States Megestrol Market Competitive Situation and Trends
        2.4.1 United States Megestrol Market Concentration Rate
        2.4.2 United States Megestrol Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Megestrol Manufacturing Base Distribution, Sales Area, Product Type

3 United States Megestrol Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Megestrol Sales and Market Share by Region (2012-2017)
    3.2 United States Megestrol Revenue and Market Share by Region (2012-2017)
    3.3 United States Megestrol Price by Region (2012-2017)

4 United States Megestrol Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Megestrol Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Megestrol Revenue and Market Share by Type (2012-2017)
    4.3 United States Megestrol Price by Type (2012-2017)
    4.4 United States Megestrol Sales Growth Rate by Type (2012-2017)

5 United States Megestrol Sales (Volume) by Application (2012-2017)
    5.1 United States Megestrol Sales and Market Share by Application (2012-2017)
    5.2 United States Megestrol Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Megestrol Players/Suppliers Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Megestrol Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Sandoz
        6.2.2 Megestrol Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sandoz Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 GSK
        6.3.2 Megestrol Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 GSK Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Mayne Pharma Inc
        6.4.2 Megestrol Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Mayne Pharma Inc Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Novartis
        6.5.2 Megestrol Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Novartis Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Mylan
        6.6.2 Megestrol Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Mylan Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Bristol Myers Squibb
        6.7.2 Megestrol Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Bristol Myers Squibb Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Abnova
        6.8.2 Megestrol Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Abnova Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Abbott
        6.9.2 Megestrol Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Abbott Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Takeda
        6.10.2 Megestrol Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Takeda Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Guccess

7 Megestrol Manufacturing Cost Analysis
    7.1 Megestrol Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Megestrol

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Megestrol Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Megestrol Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Megestrol Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Megestrol Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Megestrol Sales Volume Forecast by Type (2017-2022)
    11.3 United States Megestrol Sales Volume Forecast by Application (2017-2022)
    11.4 United States Megestrol Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer